Kyverna Therapeutics, Inc. · NASDAQ:KYTX
Cohen Fred E received 5,093 Kyverna Therapeutics, Inc. shares as an award (Form 4)
Traded May 27, 2026 · Filed May 29, 2026
On May 27, 2026, Cohen Fred E (Director) received 5,093 Kyverna Therapeutics, Inc. shares as an award, leaving 21,727 shares. Filed May 29, 2026 (Form 4).
- Awarded
- 5,093 shares
- Holding after
- 21,727 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 27, 2026 | Common Stock | Award | 5,093 | 21,727 | Direct |
Source
Related
- Kyverna Therapeutics, Inc.
- Cohen Fred E
- Kyverna Therapeutics, Inc. shareholders
- Schedule 13G · Orin Hirschman · Oct 19, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Clark Ian T · May 29, 2026
- Form 4 · Seidenberg Beth C · May 29, 2026